These findings identify a novel mechanism by which ZIKV creates a favorable environment for replication in moDCs and also suggest that SREBP2-dependent lipid metabolism is a potential therapeutic target to suppress ZIKV infection. The gene discussed is SREBF2; the disease is Zika virus infectious disease.